Stacey DaCosta Byfield

ReCAP: Treatment Patterns and Cost of Care Associated With Initial Therapy Among Patients Diagnosed With Operable Early-Stage Human Epidermal Growth Factor Receptor 2-Overexpressed Breast Cancer in the United States: A Real-World Retrospective Study.

P. Buck, C. Blauer-Peterson, S. Dacosta Byfield, 2016, Journal of Oncology Practice.